Connect with us

Business

Elevation Point Wealth Partners Reduces Stake in Oracle by 35.4%

editorial

Published

on

Elevation Point Wealth Partners LLC has significantly reduced its investment in Oracle Corporation (NYSE: ORCL), selling 6,030 shares during the second quarter of 2023. According to a recent filing with the Securities and Exchange Commission (SEC), this reduction amounts to a 35.4% decrease in their stake, leaving the firm with a total of 11,010 shares valued at approximately $2.4 million.

Several institutional investors have also adjusted their positions in Oracle. Notably, Nuveen LLC entered the market with a new stake worth $732.7 million in the first quarter. Meanwhile, Vanguard Group Inc. increased its holdings by 2.2%, now owning over 160.9 million shares valued at around $22.5 billion after acquiring an additional 3.5 million shares.

In a remarkable move, Mitsubishi UFJ Asset Management Co. Ltd. expanded its stake by 79.2% in the first quarter, reaching 4.6 million shares valued at approximately $648.6 million. Additionally, Assenagon Asset Management S.A. boosted its position by an astonishing 840.7% during the second quarter, now holding 2.1 million shares worth about $463.4 million.

As of now, institutional investors and hedge funds collectively own 42.44% of Oracle’s shares, underscoring the company’s significant appeal to major financial players.

Analysts Weigh In on Oracle’s Future

Recent evaluations by various research analysts indicate a positive outlook for Oracle. Sanford C. Bernstein raised its target price from $363 to $364, maintaining an “outperform” rating. Similarly, Morgan Stanley increased its price objective from $246 to $320, assigning an “equal weight” rating.

Other notable adjustments include Royal Bank of Canada, which reaffirmed a “sector perform” rating with a target price of $310, and Cantor Fitzgerald, which lifted its target from $271 to $400 and issued an “overweight” rating. Meanwhile, Rothschild & Co Redburn initiated coverage with a “sell” rating and a price objective of $175.

Overall, the consensus rating for Oracle stock stands at “Moderate Buy,” with an average price target of approximately $324.89.

Oracle’s Recent Financial Performance

On September 9, 2023, Oracle Corporation announced its quarterly earnings, reporting earnings per share (EPS) of $1.47. This figure fell slightly short of the consensus estimate of $1.48. The company’s revenue for the quarter reached $14.93 billion, which was below analyst expectations of $15.04 billion.

Despite this, Oracle achieved a year-over-year revenue increase of 12.2%. The firm also set its guidance for Q2 2026 at an EPS range of $1.270 to $1.310. Analysts anticipate that Oracle will post a total of $5.00 earnings per share for the current fiscal year.

Additionally, Oracle recently declared a quarterly dividend of $0.50 per share, which was paid on October 23, 2023. The dividend yield stands at 1.0%, with a payout ratio of 46.3%.

Insider Activity and Stock Performance

In insider trading news, Stuart Levey, Executive Vice President, sold 19,758 shares on October 10, 2023, for a total of approximately $5.93 million at an average price of $300 per share. Following this transaction, Levey holds 18,429 shares valued at around $5.53 million.

Another notable transaction involved Michael D. Sicilia, who sold 33,845 shares on September 23, 2023, for approximately $10.87 million, reducing his ownership by 20.33%.

In total, insiders have sold 204,254 shares valued at around $60.2 million over the past 90 days, with corporate insiders currently holding 40.9% of Oracle’s stock.

As Oracle navigates a competitive landscape in enterprise software, its ongoing adjustments in investment and stock performance highlight its strategic importance in the technology sector.

Continue Reading

Trending

Copyright © All rights reserved. This website offers general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information provided. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult relevant experts when necessary. We are not responsible for any loss or inconvenience resulting from the use of the information on this site.